ATE1 anticorps (N-Term)
-
- Antigène Voir toutes ATE1 Anticorps
- ATE1 (Arginyltransferase 1 (ATE1))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ATE1 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- ATE1 antibody was raised against the N terminal of ATE1
- Purification
- Affinity purified
- Immunogène
- ATE1 antibody was raised using the N terminal of ATE1 corresponding to a region with amino acids CCPQYTIRCRPLQFQPSKSHKKVLKKMLKFLAKGEVPKGSCEDEPMDSTM
- Top Product
- Discover our top product ATE1 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ATE1 Blocking Peptide, catalog no. 33R-1654, is also available for use as a blocking control in assays to test for specificity of this ATE1 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ATE1 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- ATE1 (Arginyltransferase 1 (ATE1))
- Autre désignation
- ATE1 (ATE1 Produits)
- Synonymes
- anticorps ATE1, anticorps Ate, anticorps CG9204, anticorps Dm-Ate1, anticorps Dmel\\CG9204, anticorps ate1, anticorps l(2)k10809, anticorps zgc:158849, anticorps AI225793, anticorps AW547406, anticorps CG9204 gene product from transcript CG9204-RA, anticorps arginyltransferase 1, anticorps arginyltransferase 1 L homeolog, anticorps Ate1, anticorps ATE1, anticorps ate1, anticorps ate1.L
- Sujet
- ATE1 is an arginyltransferase, an enzyme that is involved in posttranslational conjugation of arginine to N-terminal aspartate or glutamate residues. Conjugation of arginine to the N-terminal aspartate or glutamate targets proteins for ubiquitin-dependent degradation. Alternative splicing results in two transcript variants encoding distinct isoforms.
- Poids moléculaire
- 59 kDa (MW of target protein)
- Pathways
- SARS-CoV-2 Protein Interactome
-